Skip to main content
. 2023 Jan 18;55(3):426–431. doi: 10.1007/s11239-022-02764-9

Table 3.

Etiologies of all thrombotic events in cohort

Etiology N (%)
Malignancy 30 (40.5)
 Chemotherapy associated with increased thrombosis risk 24 (32.4)
Hypercoagulable state 7 (9.5)
Catheter-related 6 (8.1)
Recent surgery 6 (8.1)
Reduced mobility 5 (6.8)
Cardiovascular risk factors 13 (17.6)
Diagnosed/suspected ITP 3 (3.9)
Sepsis 2 (2.7)
Unprovoked PE with thrombocytopenia 1 (1.4)
Suspicious for VITT 1 (1.4)